Accendra Health Inc (ACH)

Currency in USD
3.15
0.00(0.00%)
Closed·
3.150.00(0.00%)
·
ACH is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
3.123.27
52 wk Range
1.849.55
Key Statistics
Prev. Close
3.15
Open
3.12
Day's Range
3.12-3.27
52 wk Range
1.84-9.55
Volume
621.49K
Average Vol. (3m)
947.47K
1-Year Change
-52.6316%
Book Value / Share
-5.96
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ACH Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
3.25
Upside
+3.17%
Members' Sentiments
Bearish
Bullish
ProTips
Management has been aggressively buying back shares

Accendra Health Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Accendra Health, Inc., together with its subsidiaries, operates as a healthcare solutions company in the United States. It offers a range of products and services for in-home care and delivery for diabetes treatment; home respiratory therapy, including home oxygen and non-invasive ventilation services; obstructive sleep apnea treatment, such as continuous positive airway pressure and bi-level positive airway pressure devices, and patient support services. The company also supplies other home medical equipment, patient care product lines including ostomy, wound care and negative pressure wound therapy, urology, incontinence, and other products and services. It serves patients and home health agencies. The company was formerly known as Owens & Minor, Inc. and changed its name to Accendra Health, Inc. in December 2025. Accendra Health, Inc. was founded in 1882 and is based in Glen Allen, Virginia.

Accendra Health Inc SWOT Analysis


Analyst Outlook
Price targets range from $14 to $23, with an average of $19.14, as experts weigh Owens & Minor's growth potential against increased leverage and market pressures
Market Dynamics
Explore how emerging trends like GLP-1 drugs and potential Chinese tariffs could reshape Owens & Minor's competitive landscape in healthcare distribution
Financial Flux
Mixed Q3 results and lowered guidance reflect challenges in profitability, while CFO transition sparks debates about the company's financial management
Strategic Expansion
Owens & Minor's $1.36B Rotech acquisition aims to boost its presence in the lucrative Patient Direct business, promising growth but raising integration concerns
Read full SWOT analysis

Accendra Health Inc Earnings Call Summary for Q3/2025

  • Owens & Minor reported Q3 2025 revenue of $697 million (up 1.5% YoY), with adjusted EPS of $0.25 slightly beating forecasts despite EBITDA declining to $92 million from $108 million last year.
  • The company announced a strategic pivot to become a pure-play home-based care provider, including the sale of its Products and Healthcare Services segment, simplifying its business model.
  • Stock dropped 4.98% in aftermarket trading to $5.22, reflecting investor concerns about profitability challenges and the anticipated loss of a major customer contract in 2026.
  • Management provided FY2025 guidance of $2.76-2.82 billion in revenue and adjusted EPS of $1.20-1.70, expressing cautious optimism about organic growth despite upcoming challenges.
Last Updated: 10/30/2025, 06:11 PM
Read Full Transcript
Accendra Health investor slides for Q3/2025
Owens & Minor Q3 2025 slides
Last Update: Oct 30, 2025
See full investor slides

Compare ACH to Peers and Sector

Metrics to compare
ACH
Peers
Sector
Relationship
P/E Ratio
−2.3x10.0x−0.5x
PEG Ratio
0.012.250.00
Price / Book
−0.5x2.6x2.6x
Price / LTM Sales
0.1x0.9x3.2x
Upside (Analyst Target)
−4.8%−26.8%47.6%
Fair Value Upside
Unlock30.3%6.1%Unlock

Analyst Ratings

2 Buy
2 Hold
2 Sell
Ratings:
6 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 3.25
(+3.17% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
UBS
Hold4.00+26.98%7.00DowngradeNov 03, 2025
Leerink Partners
Hold6.00+90.48%5.00MaintainOct 08, 2025
JPMorgan
Sell6.00+90.48%7.00MaintainAug 27, 2025
UBS
Buy7.00+122.22%13.00MaintainAug 13, 2025
Baird
Buy7.00+122.22%10.00MaintainAug 12, 2025

Earnings

Latest Release
Feb 19, 2026
EPS / Forecast
0.21 / 0.22
Revenue / Forecast
708.97M / 713.43M
EPS Revisions
Last 90 days

ACH Income Statement

People Also Watch

52.5700
SLNO
-0.10%
14.020
LPTH
-1.89%
2.470
AISP
+6.93%
824.01
LITE
-3.37%
55.74
GXO
-1.83%

FAQ

What Is the Accendra Health (ACH) Stock Price Today?

The Accendra Health stock price today is 3.15 USD.

What Stock Exchange Does Accendra Health Trade On?

Accendra Health is listed and trades on the New York Stock Exchange.

What Is the Stock Symbol for Accendra Health?

The stock symbol for Accendra Health is "ACH."

What Is the Accendra Health Market Cap?

As of today, Accendra Health market cap is 240.78M USD.

What Is Accendra Health's Earnings Per Share (TTM)?

The Accendra Health EPS (TTM) is -1.34.

When Is the Next Accendra Health Earnings Date?

Accendra Health will release its next earnings report on May 01, 2026.

From a Technical Analysis Perspective, Is ACH a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Accendra Health Stock Split?

Accendra Health has split 4 times.

How Many Employees Does Accendra Health Have?

Accendra Health has 6500 employees.

What is the current trading status of Accendra Health (ACH)?

As of Apr 15, 2026, Accendra Health (ACH) is trading at a price of 3.15 USD, with a previous close of 3.15 USD. The stock has fluctuated within a day range of 3.12 USD to 3.27 USD, while its 52-week range spans from 1.84 USD to 9.55 USD.

What Is Accendra Health (ACH) Price Target According to Analysts?

The average 12-month price target for Accendra Health is 3.25 USD, with a high estimate of 5 USD and a low estimate of 2.25 USD. 2 analysts recommend buying the stock, while 2 suggest selling, leading to an overall rating of Neutral. The stock has an +3.17% Upside potential.

What Is the ACH Premarket Price?

ACH's last pre-market stock price is 3.14 USD. The pre-market share volume is 710.00, and the stock has decreased by -0.01, or -0.32%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.